Day F, Sridharan S, Lynam J, Gedye C, et al. Chemoradiotherapy with concurrent durvalumab for the palliative treatment of oligometastatic oesophageal and gastrooesophageal carcinoma with dysphagia: a single arm phase II clinical trial (PALEO, sponsored by the Australasian Gastro-Intestinal Trial BMC Cancer 2022;22:1324.
PMID: 36528772